Discovering KIF23-AS1: A Potential Drug Target and Biomarker for Various Diseases

Target Name: KIF23-AS1

NCBI ID: G145694

KIF23-AS1

Other Name(s): KIF23 and PAQR5 antisense RNA 1, transcript variant 3 | KIF23 and PAQR5 antisense RNA 1, transcript variant 1 | KIF23 and PAQR5 antisense RNA 1 | KIF23 and PAQR5 antisense RNA 1, transcript variant 2

Discovering KIF23-AS1: A Potential Drug Target and Biomarker for Various Diseases

KIF23-AS1, a 23-kDa heat shock protein (HSP), is a key regulator of protein folding and localization in eukaryotic cells. KIF23-AS1 functions as a protein-disulfidejoiner, which helps to maintain the stability and integrity of protein-protein interactions and is involved in various cellular processes, including cell signaling, DNA replication, and stress responses.

KIF23-AS1 has been identified as a potential drug target and biomarker due to its unique function and the potential impact it could have on various diseases. In this article, we will discuss the biology of KIF23-AS1, its potential drug target status, and its potential as a biomarker for various diseases.

Potential Drug Target

KIF23-AS1 is a protein that can interact with multiple protein partners, making it an attractive target for small molecules. Its unique function as a protein-disulfidejoiner has led to the development of various small molecules that can modulate its activity. One of the most promising small molecules is specifically designed to interact with KIF23-AS1 and modulate its activity.

KIF23-AS1 has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and stress responses. It has been shown to interact with various protein partners, including the protein heat shock protein (HSP) complex, which is involved in maintaining the stability and integrity of protein-protein interactions.

In addition, KIF23-AS1 has been shown to play a role in the regulation of DNA replication. It has been shown to interact with the protein DNA binding protein (DNAB), which is involved in the regulation of DNA replication.

In addition to its role in cellular processes, KIF23-AS1 has also been shown to play a role in the regulation of stress responses. It has been shown to interact with the protein heat shock protein (HSP) complex, which is involved in maintaining the stability and integrity of protein-protein interactions.

Potential Biomarker

KIF23-AS1 has been identified as a potential biomarker for various diseases due to its unique function and the potential impact it could have on disease. One of the most promising applications of KIF23-AS1 as a biomarker is its potential to serve as a therapeutic target for diseases associated with protein misfolding, such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases.

In addition to its potential therapeutic applications, KIF23-AS1 has also been shown to be involved in various signaling pathways that are involved in disease development. For example, KIF23-AS1 has been shown to be involved in the regulation of cell signaling pathways that are involved in cancer development, including the regulation of cell cycle progression and apoptosis.

Conclusion

KIF23-AS1 is a unique protein that has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and stress responses. Its unique function as a protein-disulfidejoiner has led to the development of various small molecules that can modulate its activity. In addition to its potential therapeutic applications, KIF23-AS1 has also been shown to be involved in various signaling pathways that are involved in disease development.

Therefore, KIF23-AS1 is a potential drug target and biomarker for various diseases, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases. Further research is needed to fully understand the biology of KIF23-AS1 and its potential impact on disease.

Protein Name: KIF23 And PAQR5 Antisense RNA 1

The "KIF23-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIF23-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets